Across TCGA pan-cancer cohorts, RNA5SP209 RNA is linked to patient survival in 15 of 34 cancer types, making it the most broadly survival-associated RNA5SP209 data layer.
The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher RNA5SP209 RNA is associated with better overall survival. In most high-consensus cancer types, elevated RNA5SP209 expression acts as an unfavorable survival marker, although some lineages such as BLCA and LUAD show a favorable association.
BLCA, LIHC, and KIRC are the cancer types where RNA5SP209 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.